Kairemo K J
Department of Clinical Chemistry, Helsinki University Central Hospital, Finland.
Acta Oncol. 1993;32(7-8):825-30. doi: 10.3109/02841869309096142.
A review on the use of monoclonal antibodies labeled with positron emitting nuclides is presented. Potential radionuclides for labeling are e.g. 18F, 55Co, 64Cu, 66Ga, 68Ga, 76Br, 89Zr and 124I. Radionuclides with short half-lives may be utilized especially by pretargeting approaches. Gallium-isotopes have also been coupled to antibodies, using chelation methods. One promising nuclide for antibody labeling seems to be 124I (t1/2 = 4.2 d) as radioiodination of antibodies is a well-characterized procedure. Some of our own studies using 124I labeled monoclonal antibodies in a nude mouse and rat human ovarian cancer xenograft are reported.
本文对正电子发射核素标记的单克隆抗体的应用进行了综述。可用于标记的潜在放射性核素例如有18F、55Co、64Cu、66Ga、68Ga、76Br、89Zr和124I。半衰期短的放射性核素尤其可通过预靶向方法加以利用。镓同位素也已通过螯合方法与抗体偶联。124I(半衰期t1/2 = 4.2天)似乎是一种用于抗体标记的有前景的核素,因为抗体的放射性碘化是一个已充分表征的过程。报告了我们自己使用124I标记的单克隆抗体在裸鼠和大鼠人卵巢癌异种移植模型中的一些研究。